|
Volumn 1, Issue 7, 2011, Pages
|
FDA pulls approval for avastin in breast cancer.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
MONOCLONAL ANTIBODY;
BREAST TUMOR;
DRUG APPROVAL;
FEMALE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
METHODOLOGY;
NOTE;
UNITED STATES;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
BREAST NEOPLASMS;
DRUG APPROVAL;
FEMALE;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84867016210
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.cd-nd112311ol-08 Document Type: Note |
Times cited : (20)
|
References (0)
|